MedPath
FDA Approval

Kit for the Preparation of Technetium Tc99m Sestamibi

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
March 31, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries, Inc.

139261648

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Kit for the Preparation of Technetium Tc99m Sestamibi

Product Details

NDC Product Code
45567-0555
Application Number
ANDA079157
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
March 31, 2020
CYSTEINE HYDROCHLORIDEInactive
Code: ZT934N0X4WClass: IACTQuantity: 1 mg in 10 mL
Code: 971Z4W1S09Class: ACTIBQuantity: 1 mg in 10 mL
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACTQuantity: 2.6 mg in 10 mL
STANNOUS CHLORIDEInactive
Code: 1BQV3749L5Class: IACTQuantity: 0.075 mg in 10 mL
MANNITOLInactive
Code: 3OWL53L36AClass: IACTQuantity: 20 mg in 10 mL
© Copyright 2025. All Rights Reserved by MedPath